Practice Management

Practice management involves overseeing all business aspects of a medical practice including financials, human resources, information technology, compliance, marketing and operations.

New PET imager cleared for U.S. sales

A Canadian manufacturer of positron emission tomography equipment has received FDA’s OK to market a small-footprint scanner that images targeted organs bearing radiotracers at close range.

Generic CT contrast supplier pledges ‘immediate relief’ from shortage

A global tech and pharma vendor is set to inject U.S. healthcare with a set of generic contrast agents, the first of which will be an FDA-approved substitute for GE Healthcare’s Visipaque.

Medicare money payment physician

An increased need for specialists boosted radiologist salaries by 12%, according to new report

The report placed radiologists’ annual compensation 6th among the top 10 highest physician salaries.

contrast shortage

Generic, FDA approved contrast agent set to hit the market in wake of nationwide shortage

On July 18 Fresenius Kabi announced that they are rolling out a line of generic contrast media products, starting immediately with Iodixanol Injection USP. 

Thumbnail

Radiologist starting salaries up 13.5% over last year

Radiologists are receiving salary offers averaging $455,000 to start a new job in 2022, up from $401,000 in 2021.  

True or false? ‘AI does not influence radiologists’ performance’

A healthcare AI startup in Silicon Valley is partnering with a top-tier medical school—and hopefully a few good radiologists—to test a hypothesis that’s increasingly crucial to radiology.

Highly referenced breast density education hub makes patient-driven updates

Citing low health literacy as a barrier between providers and patients in overcoming healthcare disparities, DenseBreast-info.org updated their breast density materials to include more patient-friendly, “simple language.”

Contrast shortage update: FDA opens door for U.S. providers to order foreign-labeled Bayer contrast media

Per Bayer’s communications, the contrast agent is manufactured at the same site in Berlin, Germany as the Ultravist that is intended for U.S. markets, but due to its intended distribution abroad it lacks current FDA-approved labeling.